This company has been marked as potentially delisted and may not be actively trading. NYSE:PKI Revvity (PKI) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Revvity Stock (NYSE:PKI) 30 days 90 days 365 days Advanced Chart Remove Ads Get Revvity alerts:Sign Up Key Stats Today's Range N/A50-Day Range$115.24▼$137.1152-Week Range N/AVolume1.63 million shsAverage Volume851,117 shsMarket Capitalization$14.57 billionP/E Ratio15.01Dividend Yield0.24%Price TargetN/AConsensus RatingN/A Company OverviewRevvity, Inc provides health science solutions, technologies, expertise, and services that deliver complete workflows from discovery to development, and diagnosis to cure. It focuses on translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics.? The company was founded by Richard Scott Perkin and Charles W. Elmer on April 19, 1937, and is headquartered in Waltham, MA.Read More… Remove Ads Revvity Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks66th Percentile Overall ScorePKI MarketRank™: Revvity scored higher than 66% of companies evaluated by MarketBeat, and ranked 305th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Revvity. Earnings and Valuation4.4 / 5Proj. Earnings Growth17.71% Earnings GrowthEarnings for Revvity are expected to grow by 17.71% in the coming year, from $4.97 to $5.85 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Revvity is 15.01, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 21.22.Price to Earnings Ratio vs. SectorThe P/E ratio of Revvity is 15.01, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 22.89.Price to Earnings Growth RatioRevvity has a PEG Ratio of 0.50. PEG Ratios below 1 indicate that a company could be undervalued. Short InterestN/AShort Interest LevelN/A Short InterestThere is no current short interest data available for PKI. Dividend1.7 / 5Dividend StrengthWeak Dividend YieldRevvity has a dividend yield of 0.24%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthRevvity does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Revvity is 3.65%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Revvity will have a dividend payout ratio of 4.79% next year. This indicates that Revvity will be able to sustain or increase its dividend.Read more about Revvity's dividend. Sustainability and ESG3.5 / 5Environmental Score-1.99 Short InterestThere is no current short interest data available for PKI. News and Social Media0.0 / 5News SentimentN/A Search InterestOnly 1 people have searched for PKI on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Revvity insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.52% of the stock of Revvity is held by insiders.Percentage Held by Institutions85.22% of the stock of Revvity is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Revvity's insider trading history. Receive PKI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Revvity and its competitors with MarketBeat's FREE daily newsletter. Email Address PKI Stock News HeadlinesRevvity Ramps Up R&D Spending Since PerkinElmer SplitOctober 15, 2024 | msn.comRevvity, Inc. (RVTY)July 19, 2024 | finance.yahoo.comTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.April 4, 2025 | Porter & Company (Ad)Revvity Inc PKIFebruary 13, 2024 | morningstar.comRevvity Launches EONIS Q System Enabling Faster, Simplified Newborn Screening for SMA and SCIDDecember 1, 2023 | businesswire.comRevvity Stock (NYSE:RVTY), Analyst Ratings, Price Targets, PredictionsNovember 1, 2023 | benzinga.comRevvity, Inc. and Element Biosciences, Inc. Pioneer Next-Generation Sequencing Kits Market with Innovative Genomic Analysis SolutionsOctober 29, 2023 | finance.yahoo.comRevvity (RVTY) Beats on Q2 Earnings, Lowers '23 EPS ViewAugust 2, 2023 | finance.yahoo.comSee More Headlines PKI Stock Analysis - Frequently Asked Questions How were Revvity's earnings last quarter? Revvity, Inc. (NYSE:PKI) released its quarterly earnings data on Thursday, May, 11th. The medical research company reported $1.01 earnings per share for the quarter, missing analysts' consensus estimates of $1.07 by $0.06. The medical research company earned $674.87 million during the quarter, compared to analysts' expectations of $686.30 million. Revvity had a net margin of 28.94% and a trailing twelve-month return on equity of 11.17%. Is Revvity doing a stock buyback? Revvity's board initiated a stock buyback plan on Thursday, May 11th 2023, which authorizes the company to repurchase $600,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 4.1% of its shares through open market purchases. Shares buyback plans are typically an indication that the company's management believes its shares are undervalued. Does Revvity have any subsidiaries? Revvity subsidiaries include BioLegend, Immunodiagnostic Systems, Nexcelom Bioscience, SIRION Biotech, Oxford Immunotec, Horizon Discovery, Cisbio.com, and others. What other stocks do shareholders of Revvity own? Based on aggregate information from My MarketBeat watchlists, some other companies that Revvity investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), Tesla (TSLA), Meta Platforms (META), Visa (V), Home Depot (HD) and JPMorgan Chase & Co. (JPM). Company Calendar Last Earnings5/11/2023Today4/04/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Analytical instruments Sub-IndustryLife Sciences Tools & Services Current SymbolNYSE:PKI CIK31791 Webwww.perkinelmer.com Phone(781) 663-6900Fax781-663-5985Employees16,700Year Founded1937Profitability EPS (Most Recent Fiscal Year)$7.68 Trailing P/E Ratio15.01 Forward P/E RatioN/A P/E Growth0.5Net Income$569.18 million Net Margins28.94% Pretax Margin13.81% Return on Equity11.17% Return on Assets5.83% Debt Debt-to-Equity Ratio0.48 Current Ratio2.43 Quick Ratio2.15 Sales & Book Value Annual Sales$3.31 billion Price / Sales0.00 Cash FlowN/A Price / Cash Flow9.88 Book Value$58.49 per share Price / BookN/AMiscellaneous Outstanding Shares126,410,000Free Float125,755,000Market Cap$14.57 billion OptionableOptionable Beta1.10 Social Links 7 Energy Stocks to Buy and Hold ForeverWith the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.Get This Free Report This page (NYSE:PKI) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Orders 'National Digital Asset Stockpile'‘Digital Asset Reserve’ for THIS Coin??? Get all the details before this story gains even more tractionCrypto 101 Media | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredThe bigger story behind the recent market pullbackNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Revvity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Revvity With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.